Manoj Doss
This study will test the effects of psilocybin on memory and cognition in healthy participants using computerized tasks and magnetic resonance imaging (MRI).
In a double-blind, placebo-controlled, repeated measures design in healthy participants, this study will test the effects of psilocybin on memory and cognition in healthy individuals using computerized tasks and magnetic resonance imaging (MRI). A better understanding of the basic neurocognitive effects of psilocybin may allow for minimizing potential harms and maximizing potential benefits of psilocybin therapy.
Inclusion Criteria: * 21 to 45-years-old. * 3-30 lifetime psychedelic uses. * English as a first language. * High school education (or equivalent) * Psychiatrically healthy (as assessed by the SCID-5). * Medically healthy (as assessed by a physical examination and ECG). * Willingness to attend all study sessions and complete all procedures. * BMI between 19 and 30. Exclusion Criteria: * Current or past diagnosis of psychiatric disorders except panic attacks, depressive disorder, or anxiety, or disorder from ≥1 year prior. * Current or past medical conditions that might interfere with study…
This is an inactive control condition.
This is a moderate psychoactive dose.
Arctuva estimate
Verify or correct the compensation shown for this listing.